Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomised Study to Investigate the Use of Adoptive Cellular Therapy (ACT) in Combination With Conventional Antiviral Drug Therapy for the Treatment of CMV Reactivation Episodes in Patients Following Allogeneic Haematopoietic Stem Cell Transplant

NCT01077908 is registered in ClinicalTrials.gov with Cell Medica Ltd as lead sponsor.

NCT NCT01077908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01077908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomised Study to Investigate the Use of Adoptive Cellular Therapy (ACT) in Combination With Conventional Antiviral Drug Therapy for the Treatment of CMV Reactivation Episodes in Patients Following Allogeneic Haematopoietic Stem Cell Transplant
Lead sponsor
Cell Medica Ltd
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2008
Completion date
October 31, 2014
Enrollment
89 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infection